RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,304,140 | +236.6% | 1,700,849 | +402.7% | 0.00% | +200.0% |
| Q2 2023 | $4,249,236 | +124.9% | 338,315 | +194.9% | 0.00% | – |
| Q1 2023 | $1,889,422 | -11.3% | 114,719 | -19.5% | 0.00% | – |
| Q4 2022 | $2,129,847 | -78.2% | 142,560 | -67.3% | 0.00% | -100.0% |
| Q3 2022 | $9,752,000 | +117.6% | 435,940 | +62.9% | 0.00% | +100.0% |
| Q2 2022 | $4,482,000 | +49.6% | 267,619 | +167.4% | 0.00% | 0.0% |
| Q1 2022 | $2,995,000 | -61.4% | 100,094 | -60.4% | 0.00% | -50.0% |
| Q4 2021 | $7,763,000 | -0.3% | 252,759 | +2.4% | 0.00% | +100.0% |
| Q3 2021 | $7,783,000 | +67.2% | 246,847 | +94.0% | 0.00% | 0.0% |
| Q2 2021 | $4,656,000 | +6.2% | 127,251 | +0.4% | 0.00% | 0.0% |
| Q1 2021 | $4,383,000 | +67.4% | 126,773 | +101.2% | 0.00% | 0.0% |
| Q4 2020 | $2,618,000 | +13.6% | 62,997 | +16.5% | 0.00% | 0.0% |
| Q3 2020 | $2,304,000 | – | 54,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |